[
  {
    "ts": "2025-12-30T10:51:57+00:00",
    "headline": "Johnson & Johnson acquires Halda Therapeutics for $3.05bn",
    "summary": "The deal adds early-stage candidates for breast, lung, and other tumour types, using RIPTAC technology, to J&J’s pipeline.",
    "url": "https://www.pharmaceutical-technology.com/news/johnson-johnson-acquires-halda/",
    "source": "Pharmaceutical Technology",
    "provider": "yfinance",
    "raw": {
      "id": "8e55f30c-14b3-3814-b7b9-d3ef6a28d2e4",
      "content": {
        "id": "8e55f30c-14b3-3814-b7b9-d3ef6a28d2e4",
        "contentType": "STORY",
        "title": "Johnson & Johnson acquires Halda Therapeutics for $3.05bn",
        "description": "",
        "summary": "The deal adds early-stage candidates for breast, lung, and other tumour types, using RIPTAC technology, to J&J’s pipeline.",
        "pubDate": "2025-12-30T10:51:57Z",
        "displayTime": "2025-12-30T10:51:57Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharmaceutical_technology_376/e98921a004d978bc920bb7a30d4e51aa",
          "originalWidth": 1440,
          "originalHeight": 816,
          "caption": "J&J anticipates earnings dilution in the fourth quarter of 2025 and into 2026. Credit: Skorzewiak/Shutterstock.com.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/F9vTNyNzl7jPAiFIOWPkCQ--~B/aD04MTY7dz0xNDQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharmaceutical_technology_376/e98921a004d978bc920bb7a30d4e51aa.cf.webp",
              "width": 1440,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/47Jg2qpUYmm6ipTb.86sRg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharmaceutical_technology_376/e98921a004d978bc920bb7a30d4e51aa.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharmaceutical Technology",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmaceutical-technology.com/news/johnson-johnson-acquires-halda/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/johnson-johnson-acquires-halda-therapeutics-105157805.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]